Pacific Biosciences Of California reported $65.36M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Danaher USD 7.46B 653M Mar/2026
General Electric Aerospace USD 40.03B 1.05B Mar/2026
Illumina USD 1.57B 19M Mar/2026
Myriad Genetics USD 130.2M 3.6M Mar/2026
Pacific Biosciences Of California USD 65.36M 7.48M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Standard Biotools USD 42.2M 66.1M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Waters USD 1.24B 11.8M Dec/2025